NNMT INHIBITOR • INVESTIGATIONAL RESEARCH COMPOUND

5-AMINO-1MQ

Nicotinamide N-Methyltransferase Inhibitor

5-Amino-1MQ is a small-molecule research compound investigated for inhibition of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism, cellular methyl-group balance, and metabolic regulation.

NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) TARGET ENZYME
50 MG RESEARCH QUANTITY
PRECLINICAL EVIDENCE BASE

Primary Research Target

Nicotinamide N-Methyltransferase (NNMT)

NNMT is an enzyme involved in how cells process nicotinamide, a form of vitamin B3. It transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA).

01 NNMT Nicotinamide N-Methyltransferase Target Enzyme
Why NNMT Matters

NNMT participates in nicotinamide and methyl-group metabolism. Because nicotinamide is connected to NAD+ biology and NNMT uses SAM as a methyl donor, changes in NNMT activity can influence several interconnected cellular metabolic pathways.

Mechanism of Investigation

How 5-Amino-1MQ Is Studied

5-Amino-1MQ is investigated as an inhibitor of nicotinamide N-methyltransferase (NNMT). Experimental research examines how reducing NNMT activity can influence nicotinamide, NAD+, methyl-group, and metabolic pathways.

01
NNMT

NNMT Inhibition

Nicotinamide N-Methyltransferase

5-Amino-1MQ is investigated for inhibition of NNMT, an enzyme that transfers a methyl group to nicotinamide.

02
1-MNA

Nicotinamide Methylation

1-Methylnicotinamide

NNMT converts nicotinamide into 1-methylnicotinamide (1-MNA). Experimental NNMT inhibition can alter this methylation pathway.

03
NAD+

NAD+ Metabolism

Nicotinamide Adenine Dinucleotide

Because nicotinamide can participate in NAD+ salvage pathways, NNMT activity is studied in relation to intracellular NAD+ metabolism and cellular bioenergetics.

04
SAM

Methyl-Group Metabolism

S-Adenosylmethionine

NNMT uses S-adenosylmethionine (SAM) as its methyl donor, connecting NNMT activity with cellular methyl-group metabolism.

Preclinical Research

Areas of Investigation

Research involving 5-Amino-1MQ and NNMT inhibition has explored several areas of metabolic biology, primarily through laboratory and animal models.

01

Cellular Energy Metabolism

Investigation of nicotinamide metabolism, NAD+-related biology, and cellular energy-regulatory pathways.

02

Adipose Tissue Biology

Preclinical research examining adipocyte metabolism, lipid accumulation, and adipose-tissue responses associated with NNMT inhibition.

03

Glucose & Insulin Pathways

Experimental models have investigated glucose handling, insulin sensitivity, and related metabolic signaling.

04

Hepatic Metabolism

Preclinical research has examined liver lipid metabolism and other metabolic changes associated with altered NNMT activity.

Research Status

Evidence Overview

Current research should be interpreted within the context of an investigational compound whose published metabolic findings are primarily preclinical.

Compound Class Small-Molecule NNMT Inhibitor Nicotinamide N-Methyltransferase
Research Stage Investigational
Published Evidence Primarily Preclinical
U.S. Regulatory Status Not FDA Approved
Evidence Context

Findings involving adipose tissue, body composition, glucose regulation, liver metabolism, and related metabolic outcomes have primarily been reported in laboratory and animal research. These experimental findings do not establish safety or efficacy in humans.

Research Format

Available Form

5-AMINO-1MQ 50 mg

Research Powder

PRIMARY RESEARCH TARGET Nicotinamide N-Methyltransferase NNMT
Explore Research Catalog →

Research Use Only

5-Amino-1MQ is an investigational research compound. Information describing experimental mechanisms or findings from cellular and animal studies does not establish safety, efficacy, or clinical performance in humans. Provided solely for laboratory research purposes. Not for human consumption, veterinary use, diagnostic procedures, or therapeutic application.